Longitudinal Molecular Imaging of Progesterone Receptor Reveals Early Differential Response to Endocrine Therapy in Breast Cancer with an Activating ESR1 Mutation
Conclusion: Molecular imaging of PR expression dynamics could be a noninvasive approach for early identification of reduced effectiveness of endocrine therapy resulting from activating ESR1 mutations.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Kumar, M., Salem, K., Jeffery, J. J., Yan, Y., Mahajan, A. M., Fowler, A. M. Tags: Basic Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Estradiol | Genetics | Nuclear Medicine | PET Scan | Statistics | Study